| Literature DB >> 25428274 |
Toshitsugu Fujita1, Hodaka Fujii2.
Abstract
BACKGROUND: Comprehensive understanding of mechanisms of genome functions requires identification of molecules interacting with genomic regions of interest in vivo. We previously developed the insertional chromatin immunoprecipitation (iChIP) technology to isolate specific genomic regions retaining molecular interactions and identify their associated molecules. iChIP consists of locus-tagging and affinity purification. The recognition sequences of an exogenous DNA-binding protein such as LexA are inserted into a genomic region of interest in the cell to be analyzed. The exogenous DNA-binding protein fused with a tag(s) is expressed in the cell and the target genomic region is purified with antibody against the tag(s). In this study, we developed the iChIP system using recombinant DNA-binding proteins to make iChIP more straightforward than the conventional iChIP system using expression of the exogenous DNA-binding proteins in the cells to be analyzed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25428274 PMCID: PMC4253623 DOI: 10.1186/s12867-014-0026-0
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Figure 1Scheme of iChIP using r3xFNLDD-D. 3xFNLDD-D consisting of 3xFLAG-tag, a nuclear localization signal (NLS), the DNA-binding domain (DB) plus the dimerization domain of the LexA protein, and Dock-tag, is expressed and purified. The recognition sequences of the LexA protein (LexA BE) are inserted into a genomic region of interest, usually by homologous recombination, in the cell to be analyzed. The resultant cell is stimulated and crosslinked with formaldehyde or other crosslinkers, if necessary. The cell is lysed, and the genomic DNA is fragmented. The target genomic region is affinity purified with r3xFNLDD-D conjugated with anti-FLAG antibody (Ab). After reverse crosslinking, if necessary, purification of the chromatin components (DNA, RNA, proteins, other molecules) allows their identification and characterization.
Figure 2Expression and purification of r3xFNLDD-D. (A) Coomassie Brilliant Blue (CBB) staining of the recombinant protein. The purified proteins were subjected to SDS-PAGE and CBB staining. (B) Immunoblot analysis (IB) of r3xFNLDD-D. The purified proteins were subjected to SDS-PAGE and IB with anti-Dock Ab. Supernatant: the supernatant prepared from the silkworm pupal homogenates. Precipitant: the insoluble precipitate prepared from the silkworm pupal homogenates. Elution: the eluate after affinity purification with Dock Catch Resin.
Figure 3Isolation of the c 1A promoter region by iChIP using r3xFNLDD-D. (A) Scheme of the LexA BE-inserted cPax5 1A promoter region with primer positions. The positions of PCR primers with distances from the transcription start site (TSS) are indicated. (B) The results of iChIP using 10 μg of r3xFNLDD-D. % of input is shown (mean +/− SEM, n = 3). (C) Specific isolation of the target genomic region by iChIP using r3xFNLDD-D. N.D.: not detected.
Figure 4Optimization of iChIP using r3xFNLDD-D for isolation of the c 1A promoter region. (A) Titration of r3xFNLDD-D and anti-FLAG Ab. (B) Results of iChIP using 0.5 μg of each r3xFNLDD-D and anti-FLAG Ab. % of input is shown. The error bar represents the range of duplicate experiments.
Figure 5Detection of RNA associated with the c locus. (A) Scheme of iChIP. After isolation of the cPax5 locus by iChIP using r3xFNLDD-D, the nascent RNA transcribed on the exon 1A of the cPax5 gene was detected by RT-PCR. (B) Results of iChIP using 0.5 μg of each r3xFNLDD-D and anti-FLAG Ab. % of input is shown. The error bar represents the range of duplicate experiments. (C) Detection of RNA corresponding to the exon 1A of the cPax5 gene but not that corresponding to the exon 3 of the cAID gene by RT-PCR.
Primers used in this study
|
|
|
|
|
|---|---|---|---|
| 26572 | LexA-N2 | ttctctatcgataggtacctcg | Real-time PCR in Figures |
| 27428 | LexA-C-for-Pax5 | cgctgcgtggtcgagcgtactg | Real-time PCR in Figures |
| 27134 | cPax5-ChIP-UP(−0.2 k)-F | gggctcttatttcgtttttcttgtt | Real-time PCR in Figures |
| 27135 | cPax5-ChIP-UP(−0.2 k)-R | gtgcttatttgtcagcgtggttg | Real-time PCR in Figures |
| 27013 | cPax5-ChIP-UP(−10 k)-F | tccacatcgttacattgtcacttct | Real-time PCR in Figures |
| 27014 | cPax5-ChIP-UP(−10 k)-R | taaaagccctcagttcgatttattg | Real-time PCR in Figures |
| 26552 | cPax5-inExon1A-F | cctaaaacgtttagtttcagctcagt | RT-PCR in Figure |
| 26553 | cPax5-inExon1A-R | ttcgtggctctctcaggtca | RT-PCR in Figure |
| 27571 | cAID-Ex3-F | catgtggaggttctcttcctacg | RT-PCR in Figure |
| 27572 | cAID-Ex3-R | caagtttgggtaggcacgaag | RT-PCR in Figure |
| 26773 | 18SrRNA-F2 | cttagagggacaagtggcg | RT-PCR in Additional file |
| 26774 | 18SrRNA-R2 | acgctgagccagtcagtgta | RT-PCR in Additional file |
| 27420 | hHS5-TAL-Target-F | ccagtttctccagtttccctttt | Real-time PCR in Additional file |
| 27421 | hHS5-TAL-Target-R | ttttcaaaatgcaaggtgatgtc | Real-time PCR in Additional file |
| 27310 | hIRF1-prom-F | cgcctgcgttcgggagatatac | Real-time PCR in Additional file |
| 27312 | hIRF1-prom-R1 + 2 | ctgtcctctcactccgccttgt | Real-time PCR in Additional file |